FDA panel to debate US approval for Alzheimer's drug from Eisai and Biogen

(Reuters) - A panel of experts on Friday will discuss whether to recommend traditional U.S. regulatory approval for Eisai and Biogen's new Alzheimer's...

Related Keywords

Bengaluru ,Karnataka ,India ,Chicago ,Illinois ,United States ,Americans ,Leroy Leo ,Julie Steenhuysen ,Caroline Humer ,Colin Bristow ,Alzheimer Association ,Reuters ,Drug Administration ,Wall Street ,Bill Berkrot , ,